The coexistence of carotid and lower extremity atherosclerosis further increases cardio-cerebrovascular risk in type 2 diabetes.
[Effect of tongmal recipe on atherosclerosis in patients with early lower extremity arteriopathy caused by type 2 diabetes mellitus].
The combination of carotid and lower extremity ultrasonography increases the detection of atherosclerosis in type 2 diabetes patients.
Liraglutide for Lower Limb Perfusion in People With Type 2 Diabetes and Peripheral Artery Disease: The STARDUST Randomized Clinical Trial.
Caruso P, Maiorino MI, Longo M, Porcellini C, Matrone R, Digitale Selvaggio L, Gicchino M, Carbone C, Scappaticcio L, Bellastella G, Giugliano D, Esposito K.
JAMA Netw Open. 2024 Mar 4;7(3):e241545. doi: 10.1001/jamanetworkopen.2024.1545.
Challenges and opportunities in the management of type 2 diabetes in patients with lower extremity peripheral artery disease: a tailored diagnosis and treatment review.
Mahé G, Aboyans V, Cosson E, Mohammedi K, Sarlon-Bartoli G, Lanéelle D, Mirault T, Darmon P.
Cardiovasc Diabetol. 2024 Jun 26;23(1):220. doi: 10.1186/s12933-024-02325-9.
Design and baseline characteristics of the STRIDE trial: evaluating semaglutide in people with symptomatic peripheral artery disease and type 2 diabetes.
Bonaca MP, Catarig AM, Hansen Y, Houlind K, Ramesh CK, Ludvik B, Nordanstig J, Rasouli N, Sourij H, Verma S.
Eur Heart J Cardiovasc Pharmacother. 2025 Jan 11;10(8):728-737. doi: 10.1093/ehjcvp/pvae071.
Factors associated with severe lower extremity artery disease in type 2 diabetes based on a large scale claims database in Japan.
Horii T, Kawaguchi M, Ikegami Y, Oikawa Y, Shimada A, Mihara K.
Sci Rep. 2025 Jun 3;15(1):19358. doi: 10.1038/s41598-025-03797-9.
Cholesterol-Lowering Agents.
Rosenson RS, Hegele RA, Koenig W.
Circ Res. 2019 Feb;124(3):364-385. doi: 10.1161/CIRCRESAHA.118.313238.
Impact of Diabetes on Outcomes of Patients With Lower Extremity Artery Disease.
Behrendt CA, Lareyre F, Raffort J.
Angiology. 2022 Jul;73(6):493-494. doi: 10.1177/00033197221074413. Epub 2022 Feb 9.
Neutrophil-to-lymphocyte ratio in type 2 diabetes patients combined with Lower Extremity Peripheral Artery Disease.
Li L, Wang M, Jia T, Jiang X, Yang F, Wang Z, Zhang X.
Front Endocrinol (Lausanne). 2024 Aug 30;15:1434580. doi: 10.3389/fendo.2024.1434580. eCollection 2024.
Risk of severe lower extremity arterial disease in elderly Japanese patients with type 2 diabetes: a propensity score-matched model analysis of sodium-glucose cotransporter 2 inhibitors versus metformin.
Horii T, Kawaguchi M, Ikegami Y, Oikawa Y, Shimada A, Mihara K.
BMJ Open Diabetes Res Care. 2025 Jul 17;13(4):e005103. doi: 10.1136/bmjdrc-2025-005103.
Sleep disturbance exacerbates atherosclerosis in type 2 diabetes mellitus.
Fan B, Tang T, Zheng X, Ding H, Guo P, Ma H, Chen Y, Yang Y, Zhang L.
Front Cardiovasc Med. 2023 Dec 1;10:1267539. doi: 10.3389/fcvm.2023.1267539. eCollection 2023.
Werner Syndrome.
Oshima J, Hisama FM.
2002 Dec 2 [updated 2026 Mar 25]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.
